NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia

IntroductionAcute myeloid leukemia (AML) is an aggressive blood cancer with high heterogeneity and poor prognosis. Although the metabolic reprogramming of nicotinamide adenine dinucleotide (NAD) has been reported to play a pivotal role in the pathogenesis of acute myeloid leukemia (AML), the prognos...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuncan Cao, Wenjing Shu, Peng Jin, Jianfeng Li, Hongming Zhu, Xinjie Chen, Yongmei Zhu, Xi Huang, Wenyan Cheng, Yang Shen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-06-01
Edice:	Frontiers in Immunology
Témata:	acute myeloid leukemia NAD metabolism prognostic signature immune microenvironment targeted therapy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1417398/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!